Cargando…
Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma
BACKGROUND: Ribonucleotide reductase regulatory subunit M2 (RRM2) has been reported to be an oncogene in some malignant tumors, such as lung adenocarcinoma, oral squamous cell carcinoma, glioblastoma, and breast cancer. However, the clinical significance of RRM2 in hepatocellular carcinoma has been...
Autores principales: | Qin, Zhongqiang, Xie, Bo, Qian, Jingyu, Ma, Xiang, Zhang, Lan, Wei, Jianzhu, Wang, Zhaoying, Fan, Longfei, Zhu, Ziyi, Qian, Zhen, Yin, Hongxiang, Zhu, Fangquan, Tan, Yulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086364/ https://www.ncbi.nlm.nih.gov/pubmed/37056349 http://dx.doi.org/10.3389/fonc.2023.1144269 |
Ejemplares similares
-
Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023) -
High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma
por: Mao, Guochao, et al.
Publicado: (2022) -
High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
por: Mao, Guochao, et al.
Publicado: (2022) -
miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B
por: Zhang, Qifan, et al.
Publicado: (2019) -
SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023)